579 related articles for article (PubMed ID: 31896067)
41. Serum exosomal long noncoding RNAs as a diagnostic biomarker for atrial fibrillation.
Kang JY; Mun D; Kim H; Yun N; Joung B
Heart Rhythm; 2022 Sep; 19(9):1450-1458. PubMed ID: 35660473
[TBL] [Abstract][Full Text] [Related]
42. Characterization of lncRNA Profiles of Plasma-Derived Exosomes From Type 1 Diabetes Mellitus.
Pang H; Fan W; Shi X; Li J; Wang Y; Luo S; Lin J; Huang G; Li X; Xie Z; Zhou Z
Front Endocrinol (Lausanne); 2022; 13():822221. PubMed ID: 35634499
[TBL] [Abstract][Full Text] [Related]
43. Exosomal non-coding RNAs: a promising cancer biomarker.
Yang H; Fu H; Xu W; Zhang X
Clin Chem Lab Med; 2016 Dec; 54(12):1871-1879. PubMed ID: 27166723
[TBL] [Abstract][Full Text] [Related]
44. The Significance of Exosomal RNAs in the Development, Diagnosis, and Treatment of Gastric Cancer.
Zhao G; Zhou A; Li X; Zhu S; Wang Y; Zhang S; Li P
Genes (Basel); 2021 Jan; 12(1):. PubMed ID: 33430032
[TBL] [Abstract][Full Text] [Related]
45. Tumor-Derived Exosomes Mediate the Instability of Cadherins and Promote Tumor Progression.
Wang B; Tan Z; Guan F
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357383
[TBL] [Abstract][Full Text] [Related]
46. Exosomal noncoding RNAs in Glioma: biological functions and potential clinical applications.
Cheng J; Meng J; Zhu L; Peng Y
Mol Cancer; 2020 Mar; 19(1):66. PubMed ID: 32213181
[TBL] [Abstract][Full Text] [Related]
47. Molecular functions and therapeutic applications of exosomal noncoding RNAs in cancer.
Liu QW; He Y; Xu WW
Exp Mol Med; 2022 Mar; 54(3):216-225. PubMed ID: 35352001
[TBL] [Abstract][Full Text] [Related]
48. The diagnostic role and mechanistic functions of exosomal lncRNAs in prostate cancer.
Zhou H; Wan H; Feng Y; Zhu L; Mi Y
Clin Transl Oncol; 2023 Mar; 25(3):592-600. PubMed ID: 36266385
[TBL] [Abstract][Full Text] [Related]
49. Exosomal long non-coding RNAs in the diagnosis and oncogenesis of pancreatic cancer.
Robless EE; Howard JA; Casari I; Falasca M
Cancer Lett; 2021 Mar; 501():55-65. PubMed ID: 33359452
[TBL] [Abstract][Full Text] [Related]
50. Exosomal Noncoding RNAs in Hepatobiliary Cancer: A Rising Star.
Zheng W; Ji D; Zhou Y; Yu L; Huang P; Zheng Y; Meng N; Wang H; Bai X; Huang Z; Chen W; Yam JWP; Xu Y; Cui Y
Mol Cancer Ther; 2021 Oct; 20(10):1777-1788. PubMed ID: 34376575
[TBL] [Abstract][Full Text] [Related]
51. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19.
Ren J; Ding L; Zhang D; Shi G; Xu Q; Shen S; Wang Y; Wang T; Hou Y
Theranostics; 2018; 8(14):3932-3948. PubMed ID: 30083271
[TBL] [Abstract][Full Text] [Related]
52. Circulating exosomes and exosomal microRNAs as biomarkers in gastrointestinal cancer.
Nedaeinia R; Manian M; Jazayeri MH; Ranjbar M; Salehi R; Sharifi M; Mohaghegh F; Goli M; Jahednia SH; Avan A; Ghayour-Mobarhan M
Cancer Gene Ther; 2017 Feb; 24(2):48-56. PubMed ID: 27982021
[TBL] [Abstract][Full Text] [Related]
53. Exosomal microRNAs and long noncoding RNAs: Novel mediators of drug resistance in lung cancer.
Taghvimi S; Vakili O; Soltani Fard E; Khatami SH; Karami N; Taheri-Anganeh M; Salehi M; Negahdari B; Ghasemi H; Movahedpour A
J Cell Physiol; 2022 Apr; 237(4):2095-2106. PubMed ID: 35128660
[TBL] [Abstract][Full Text] [Related]
54. Crosstalk of Exosomal Non-Coding RNAs in The Tumor Microenvironment: Novel Frontiers.
Jia Z; Jia J; Yao L; Li Z
Front Immunol; 2022; 13():900155. PubMed ID: 35663957
[TBL] [Abstract][Full Text] [Related]
55. Exosomal Long Noncoding RNAs in NSCLC: Dysfunctions and Clinical Potential.
Lin H; Li J; Wang M; Zhang X; Zhu T
J Cancer; 2023; 14(10):1736-1750. PubMed ID: 37476194
[TBL] [Abstract][Full Text] [Related]
56. Exosomal Long Noncoding RNAs are Differentially Expressed in the Cervicovaginal Lavage Samples of Cervical Cancer Patients.
Zhang J; Liu SC; Luo XH; Tao GX; Guan M; Yuan H; Hu DK
J Clin Lab Anal; 2016 Nov; 30(6):1116-1121. PubMed ID: 27184657
[TBL] [Abstract][Full Text] [Related]
57. High throughput sequencing identifies breast cancer-secreted exosomal LncRNAs initiating pulmonary pre-metastatic niche formation.
Feng T; Zhang P; Sun Y; Wang Y; Tong J; Dai H; Hua Z
Gene; 2019 Aug; 710():258-264. PubMed ID: 31176731
[TBL] [Abstract][Full Text] [Related]
58. Exosomal MALAT1 derived from hepatic cells is involved in the activation of hepatic stellate cells via miRNA-26b in fibrosis induced by arsenite.
Dai X; Chen C; Xue J; Xiao T; Mostofa G; Wang D; Chen X; Xu H; Sun Q; Li J; Wei Y; Chen F; Quamruzzaman Q; Zhang A; Liu Q
Toxicol Lett; 2019 Nov; 316():73-84. PubMed ID: 31513886
[TBL] [Abstract][Full Text] [Related]
59. RNA sequencing of plasma exosomes revealed novel functional long noncoding RNAs in hepatocellular carcinoma.
Huang X; Sun L; Wen S; Deng D; Wan F; He X; Tian L; Liang L; Wei C; Gao K; Fu Q; Li Y; Jiang J; Zhai R; He M
Cancer Sci; 2020 Sep; 111(9):3338-3349. PubMed ID: 32506598
[TBL] [Abstract][Full Text] [Related]
60. Tumor-originated exosomal lncUEGC1 as a circulating biomarker for early-stage gastric cancer.
Lin LY; Yang L; Zeng Q; Wang L; Chen ML; Zhao ZH; Ye GD; Luo QC; Lv PY; Guo QW; Li BA; Cai JC; Cai WY
Mol Cancer; 2018 Apr; 17(1):84. PubMed ID: 29690888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
